Ozanimod as Induction and Maintenance Therapy for Ulcerative ColitisNEW ENGLAND JOURNAL OF MEDICINEIF78.52021-09-30290OA
Long-term Efficacy and Tolerability of RPC4046 in an Open-Label Extension Trial of Patients With Eosinophilic EsophagitisCLINICAL GASTROENTEROLOGY AND HEPATOLOGYIF122021-03-0160OAAI
Ozanimod induction therapy for patients with moderate to severe Crohn's disease: a single-arm, phase 2, prospective observer-blinded endpoint studyLANCET GASTROENTEROLOGY & HEPATOLOGYIF38.62020-09-01106PREAI
An anti-IL-13 antibody reverses epithelial-mesenchymal transition biomarkers in eosinophilic esophagitis: Phase 2 trial resultsJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22020-08-0136OAAI
A phase I, dose-escalation study of PF-06650808, an anti-Notch3 antibody-drug conjugate, in patients with breast cancer and other advanced solid tumorsINVESTIGATIONAL NEW DRUGSIF2.72019-03-1846PREAI
Clinical remission demonstrated with oral ozanimod in the overall population and across multiple subgroups of patients with moderately to severely active ulcerative colitis in the TOUCHSTONE trialJOURNAL OF CROHNS & COLITISIF8.72019-01-252OAAI
A randomized study comparing the pharmacokinetics of the potential biosimilar PF-06438179/GP1111 with Remicade® (infliximab) in healthy subjects (REFLECTIONS B537-01)EXPERT REVIEW OF CLINICAL IMMUNOLOGYIF3.72018-03-1222PREAI
A phase 1, dose-escalation study of PF-06664178, an anti-Trop-2/Aur0101 antibody-drug conjugate in patients with advanced or metastatic solid tumorsINVESTIGATIONAL NEW DRUGSIF2.72018-01-1572OAAI
First-in-human trial of an anti-5T4 antibody-monomethylauristatin conjugate, PF-06263507, in patients with advanced solid tumorsINVESTIGATIONAL NEW DRUGSIF2.72017-01-0937OAAI
ESTABLISHING MARGINS TO DEMONSTRATE EQUIVALENCE IN EFFICACY FOR BIOSIMILAR CLINICAL TRIALS IN RHEUMATOID ARTHRITIS PATIENTS: A META-ANALYSIS APPROACHANNALS OF THE RHEUMATIC DISEASESIF20.62015-06-010PREAI
IMMUNOGENICITY ASSESSMENT OF PF-06438179, A POTENTIAL BIOSIMILAR TO INFLIXIMAB, IN HEALTHY VOLUNTEERSANNALS OF THE RHEUMATIC DISEASESIF20.62015-06-017PREAI
Activity of an alcohol-based hand gel against human adeno-, rhino-, and rotaviruses using the fingerpad methodINFECTION CONTROL AND HOSPITAL EPIDEMIOLOGYIF32015-01-0286PREAI
A PHASE I PHARMACOKINETICS TRIAL COMPARING PF-06438179 (A POTENTIAL BIOSIMILAR) AND INFLIXIMAB IN HEALTHY VOLUNTEERS (REFLECTIONS B537-01)ANNALS OF THE RHEUMATIC DISEASESIF20.62014-06-014PREAI
Intraocular pressure-lowering efficacy of brinzolamide 1%/timolol 0.5% fixed combination compared with brinzolamide 1% and timolol 0.5%OPHTHALMOLOGYIF9.52008-10-0135PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向